MGNX

MGNX · MacroGenics Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

MGNX mentioned in medical stock sector review. MacroGenics was included in a recent Yahoo Finance article examining the performance of medical stocks this year. The stock is currently trading near its 52-week low, with technical indicators showing weakness near key support levels. This context highlights the broader sector trends affecting the company's valuation.

this person other insiders at MGNX

Insiders & Stakes

BIOTECH TARGET N V
10% Owner
9,929,963
Shares held
Koenig Scott
President and CEO
867,240
Shares held
Karrels James
SVP, CFO and Secretary
206,037
Shares held
Bonvini Ezio
Sr VP, Research & CSO
193,799
Shares held
William K. Heiden
Director
114,750
Shares held
Risser Eric Blasius
Chief Operating Officer
77,169
Shares held
HURWITZ EDWARD
Director
47,824
Shares held
Spitznagel Thomas
Sr VP, Technical Ops
38,543
Shares held
Eck Stephen L.
Chief Medical Officer
29,377
Shares held
David C. Stump
Director
14,750
Shares held
Federica F. O'Brien
Director
14,750
Shares held
Jackson Scott Thomas
Director
14,750
Shares held
SIEGEL JAY PHILIP
Director
14,750
Shares held
Liu Margaret
Director
14,750
Shares held
Chhabra Meenu
Director
14,750
Shares held
Ferrante Karen Jean
Director
14,750
Shares held
Smith Beth Ann
VP, Controller & Treasurer
12,781
Shares held
Cilinski Lynn
VP, Controller and Treasurer
6,213
Shares held
Peters Jeffrey Stuart
Senior VP and General Counsel
0
Shares held

Transaction History

Bonvini Ezio▲ Buy$21K
Peters Jeffrey Stuart▼ Sell$129K
Bonvini Ezio▲ Buy$104K
Federica F. O'Brien▲ Buy—
William K. Heiden▲ Buy—
SIEGEL JAY PHILIP▲ Buy—
Jackson Scott Thomas▲ Buy—
Liu Margaret▲ Buy—
Chhabra Meenu▲ Buy—
HURWITZ EDWARD▲ Buy—
David C. Stump▲ Buy—
Ferrante Karen Jean▲ Buy—
Bonvini Ezio▲ Buy—
Bonvini Ezio▼ Sell$11K
Smith Beth Ann▲ Buy—
Smith Beth Ann▼ Sell$723
Karrels James▲ Buy—
Karrels James▼ Sell$10K
Peters Jeffrey Stuart▲ Buy—
Peters Jeffrey Stuart▼ Sell$9K
Spitznagel Thomas▲ Buy—
Spitznagel Thomas▼ Sell$9K
Risser Eric Blasius▲ Buy—
Risser Eric Blasius▼ Sell$11K
Koenig Scott▲ Buy$0
Smith Beth Ann▼ Sell$1K
Risser Eric Blasius▼ Sell$8K
Risser Eric Blasius▲ Buy—
Koenig Scott▲ Buy—
Spitznagel Thomas▲ Buy—
Spitznagel Thomas▼ Sell$6K
Smith Beth Ann▲ Buy—
Peters Jeffrey Stuart▲ Buy—
Peters Jeffrey Stuart▼ Sell$6K
Karrels James▲ Buy—
Karrels James▼ Sell$7K
Bonvini Ezio▲ Buy—
Bonvini Ezio▼ Sell$8K
Risser Eric Blasius▲ Buy—
Risser Eric Blasius▼ Sell$5K
Peters Jeffrey Stuart▲ Buy—
Spitznagel Thomas▲ Buy—
Spitznagel Thomas▼ Sell$4K
Smith Beth Ann▲ Buy—
Smith Beth Ann▼ Sell$2K
Peters Jeffrey Stuart▼ Sell$4K
Karrels James▲ Buy—
Karrels James▼ Sell$4K
Bonvini Ezio▲ Buy—
Bonvini Ezio▼ Sell$5K
William K. Heiden▲ Buy$74K
William K. Heiden▲ Buy$77K
Koenig Scott▲ Buy$0
Koenig Scott▲ Buy$0
Federica F. O'Brien▲ Buy—
Jackson Scott Thomas▲ Buy—
William K. Heiden▲ Buy—
David C. Stump▲ Buy—
Ferrante Karen Jean▲ Buy—
Liu Margaret▲ Buy—
HURWITZ EDWARD▲ Buy—
Chhabra Meenu▲ Buy—
SIEGEL JAY PHILIP▲ Buy—
Koenig Scott▲ Buy$0
Peters Jeffrey Stuart▲ Buy$0
Bonvini Ezio▲ Buy$0
Karrels James▲ Buy$0
Karrels James▼ Sell$15K
Peters Jeffrey Stuart▼ Sell$13K
Risser Eric Blasius▲ Buy$0
Risser Eric Blasius▼ Sell$16K
Smith Beth Ann▲ Buy$0
Smith Beth Ann▼ Sell$1K
Spitznagel Thomas▲ Buy$0
Spitznagel Thomas▼ Sell$14K
Eck Stephen L.▲ Buy$0
Eck Stephen L.▼ Sell$13K
Karrels James▼ Sell$10K
Smith Beth Ann▼ Sell$2K
Spitznagel Thomas▼ Sell$10K
Peters Jeffrey Stuart▼ Sell$9K
Peters Jeffrey Stuart▲ Buy—
Spitznagel Thomas▲ Buy—
Smith Beth Ann▲ Buy—
Koenig Scott▲ Buy$0
Eck Stephen L.▲ Buy$0
Eck Stephen L.▼ Sell$9K
Bonvini Ezio▲ Buy—
Bonvini Ezio▼ Sell$11K
Risser Eric Blasius▲ Buy—
Risser Eric Blasius▼ Sell$11K
Karrels James▲ Buy—
Koenig Scott▼ Sell—
Koenig Scott▼ Sell—
Koenig Scott▼ Sell—
Koenig Scott▼ Sell—
William K. Heiden▲ Buy$0
Jackson Scott Thomas▲ Buy$0
David C. Stump▲ Buy$0
Federica F. O'Brien▲ Buy$0
Liu Margaret▲ Buy$0
Chhabra Meenu▲ Buy$0
SIEGEL JAY PHILIP▲ Buy$0
Ferrante Karen Jean▲ Buy$0
HURWITZ EDWARD▲ Buy$0
Peters Jeffrey Stuart▲ Buy$205K
Peters Jeffrey Stuart▼ Sell$640K
Peters Jeffrey Stuart▼ Sell$2K
Peters Jeffrey Stuart▼ Sell$4K
Peters Jeffrey Stuart▼ Sell$95K
Peters Jeffrey Stuart▼ Sell$58K
Peters Jeffrey Stuart▲ Buy$125K
Peters Jeffrey Stuart▲ Buy$89K
Peters Jeffrey Stuart▼ Sell$422K
Karrels James▼ Sell$615K
Risser Eric Blasius▲ Buy$152K
Risser Eric Blasius▼ Sell$300K
Risser Eric Blasius▼ Sell$514K
Spitznagel Thomas▲ Buy$115K
Spitznagel Thomas▼ Sell$200K
Peters Jeffrey Stuart▼ Sell$278K
Peters Jeffrey Stuart▲ Buy$0
Peters Jeffrey Stuart▼ Sell$173K
Bonvini Ezio▲ Buy$0
Bonvini Ezio▼ Sell$160K
Eck Stephen L.▲ Buy$0
Eck Stephen L.▼ Sell$120K
Peters Jeffrey Stuart▲ Buy$0
Peters Jeffrey Stuart▼ Sell$77K
Koenig Scott▲ Buy$0
Koenig Scott▼ Sell$250K
Cilinski Lynn▲ Buy$0
Cilinski Lynn▼ Sell$41K
Risser Eric Blasius▲ Buy$0
Risser Eric Blasius▼ Sell$102K
Karrels James▲ Buy$0
Karrels James▼ Sell$93K
Spitznagel Thomas▲ Buy$0
Spitznagel Thomas▼ Sell$87K
Bonvini Ezio▲ Buy$0
Bonvini Ezio▼ Sell$102K
Bonvini Ezio▼ Sell$60K
Peters Jeffrey Stuart▲ Buy$222K
Peters Jeffrey Stuart▼ Sell$897K
Peters Jeffrey Stuart▼ Sell$361K
Peters Jeffrey Stuart▲ Buy$625K
Bonvini Ezio▼ Sell$200K
Bonvini Ezio▼ Sell$160K
Bonvini Ezio▼ Sell$190K
BIOTECH TARGET N V▲ Buy$670K
BIOTECH TARGET N V▲ Buy$1.1M
HURWITZ EDWARD▲ Buy$74K
Peters Jeffrey Stuart▼ Sell$32K
Peters Jeffrey Stuart▲ Buy$0
Peters Jeffrey Stuart▼ Sell$22K
Bonvini Ezio▲ Buy$0
Bonvini Ezio▼ Sell$24K
BIOTECH TARGET N V▲ Buy$2.5M
BIOTECH TARGET N V▲ Buy$795K
BIOTECH TARGET N V▲ Buy$1.1M
BIOTECH TARGET N V▲ Buy$1.2M
BIOTECH TARGET N V▲ Buy$1.8M
Risser Eric Blasius▲ Buy$13K
BIOTECH TARGET N V▲ Buy$1.1M
BIOTECH TARGET N V▲ Buy$1.2M
BIOTECH TARGET N V▲ Buy$1.1M
BIOTECH TARGET N V▲ Buy$624K
Karrels James▲ Buy$99K
Koenig Scott▲ Buy$80K
Bonvini Ezio▲ Buy$0
Bonvini Ezio▼ Sell$7K
Karrels James▲ Buy$13K
Risser Eric Blasius▲ Buy$470
BIOTECH TARGET N V▲ Buy$3.7M
Bonvini Ezio▲ Buy$41K
BIOTECH TARGET N V▲ Buy$2.0M
BIOTECH TARGET N V▲ Buy$2.1M
BIOTECH TARGET N V▲ Buy$4.0M
BIOTECH TARGET N V▲ Buy$8.4M

We use analytics to understand how market-wall is used. No personal data is sold.